article · The Lancet HIV

HIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trial

Linda-Gail Bekker
Dhayendre Moodley
Nishanta Singh
Ishana Harkoo
Ravindre Panchia
Pamela Wong
Jared M. Baeten
Lillian Mworeko
Christoph C Carter
Moupali Das
Moelo Malahleha
Dázon Dixon Diallo
Cheryl Louw
John Ling
N. Kiwanuka
Andrea Brown
Renu Singh
Godfrey Kigozi
Priyanka Arora
Sarah B Puryear
Marjorie Imperial
Thesla Palanee-Phillips
Flavia Matovu Kiweewa

2026University of the Witwatersrand

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

HIV/AIDS drug development and treatment
HIV/AIDS Research and Interventions
Cytomegalovirus and herpesvirus research

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/s2352-3018(26)00112-8

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.